|
Zucker, Stephen MD
Division: Digestive Diseases
Title: Associate Professor of Medicine
Education: Bachelor of Arts (Biochemistry), Swarthmore College; Doctor of Medicine, Harvard Medical School
Training: Intern in Medicine
Brigham and Women's Hospital, Boston, MA
Resident in Medicine
Brigham and Women's Hospital, Boston, MA
Fellow in Gastroenterology
Brigham and Women's Hospital, Boston, MA
Clinical Interests: Liver diseases (primarily cholestatic liver disease)
Research Interests: Physiological functions of bilirubin, chemoprevention of colorectal cancer, hepatic inflammation, pathogenesis of kernicterus
Recent Publications:
Wang WW, Smith DL, Zucker SD. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology. 2004 Aug;40(2):424-33.
Keshavan P, Deem TL, Schwemberger SJ, Babcock GF, Cook-Mills JM, Zucker SD. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J. Immunol. 2005; 174: 3709-3718.
Smith DLH, Shire NJ, Watts NB, Schmitter T, Szabo G, Zucker SD. Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease. J. Clin. Densitom. 2006; 9:105-113.
Ahmed K, Zucker SD. Giant cell hepatitis in teenage women. Clin. Gastroenterol. Hepatol. 2008; 6:A26-A26.e1.
Limketkai BN, Zucker SD. Hyperammonemic encephalopathy caused by carnitine deficiency. J. Gen. Intern Med. 2008; 23:210-213.
Notes: Gastroenterology Fellowship Program Director. Dr. Zucker joined the University of Cincinnati College of Medicine's staff in September, 1998. He previously held the position of Instructor in Medicine and Associate Physician at Harvard Medical School and the Brigham & Women's Hospital in Boston. Dr. Zucker's primary interests are in the areas of Liver Disease. Dr. Zucker is Board Certified in Internal Medicine and Gastroenterology.
Email: zuckersd@email.uc.edu
|
 |
|
